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The study is an attempt to assess the effects of a traditional Mongolian medicine, Jonlon-5, against inflammation in an 
animal model. Both acute and sub-acute toxicity of Jonlon-5 were evaluated. The level of acute toxicity of Jonlon-5 was 
determined in accordance with the current guidelines by Organization for Economic Co-operation and Development 
(OECD). A sub-acute toxicity study was done by oral administration of Jonlon-5 with doses of 100, 200, and 500 mg/kg 
body weight/daily for 28 days. Paw edema was produced by a sub-plantar injection of 1% carrageenan. Biochemical and 
immunological analyses were performed at the end of the study. No adverse effects of Jonlon-5 were observed even at doses 
up to 2000 mg/kg/day. In the sub-acute study, there was a significant increase (p<0.05) in the activity of serum liver 
enzymes of rats, administered with 500 mg/kg body weight of Jonlon-5. The results demonstrate that Jonlon-5 can 
significantly reduce paw edema and inhibit the production of malondialdehyde (MDA), tumor necrosis factor-α and 
interleukin-1β (p<0.05). Our findings suggest that Jonlon-5 has anti-inflammatory effects in carrageenan-induced in rats 
with arthritis. However, intake of high doses may exhibit mild liver toxicity.  
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The number of people with arthritis is rising  
rapidly around the world1,2. Arthritis is one  
of the leading causes of disability among adults and  
is very costly in both personal and economic terms2. 
Despite many advances in the management of 
arthritis, progress on finding a cure remains elusive. 
This is because currently available anti-arthritis 
medications have adverse effects with long-term use, 
creating the need for more effective and safe 
treatment options. An alternative with some 
advantages, such as fewer side effects and lower cost, 
is herbal medicine3.  
In traditional Mongolian medicine, Jonlon-5, a 
mixed herbal medicine, is used to treat fever, 
infection, arthritis and heart disease4. Jonlon-5 tastes 
bitter and has a cool potency. It is composed  
of five herbs: Radix Sophoroe alopecuroides, Herba 
Gentianaebar batae, Fructus Gardeniae jasminoides, 
Fructus Terminaliae chebulae and Fructus 
Terminaliae belliricae. Previous phytochemical 
studies have revealed that Jonlon-5 contains  
alkaloids (mainly matrine and oxymatrine), 
flavonoids, saponin, and organic oxides5. 
S. alopecuroides. L (Unegen suulkhei lider), the 
main compound in Jonlon-5, is rich in alkaloids and 
flavonoids and has anti-inflammatory, anti-oxidative 
and anti-bacterial effects6,7. G. barbatae (Sormuust 
degd) and its main active alkaloids, flavonoids, 
xanthone, and secoridoids have been found to have  
anti-inflammatory, hepato-protective, and anti-
oxidative effects7-10. G. Jasminoides (Arur), containing 
geniposide, genipin and crocetin has a broad spectrum 
of therapeutic effects that include anti-oxidative, anti-
inflammatory, anti-thrombosis and anti-atherosclerosis 
activities11. Evidence from previous pharmacological 
and ethno-medical studies have shown that T. Chebula 
(Jurur) exhibits anti-bacterial, anti-inflammatory, 
immune-modulatory, hypoglycemic, anti-oxidative and 
analgesic effects and confers hepatic protection12,13. 
T. bellirica (Barur) has been reported to have analgesic, 
anti-inflammatory, anti-secretory and hepato-protective 
activities14,15. The latter 02 plants are rich  
in gallic acid, which has strong anti-oxidative activity 
in human tissues16.  ——————— *Corresponding author 
DAVAADULAM et al.: TRADITIONAL HERBAL FORMULA JONLON-5 DECOCTION FOR ANTI-INFLAMMATORY 
 
 
819
The traditional approach of combining several 
herbal medicines has been found to be more effective 
than administering them in isolation17. Given 
evidence that Jonlon-5 and its herbal components 
have potential anti-bacterial, anti-inflammatory and 
anti-oxidative activities, we hypothesized that Jonlon-
5 could be a safe and effective medication against 
inflammation. In the present study, we investigated 
the anti-inflammatory activity of Jonlon-5 on animals 
that were induced with paw edema. The acute and 
sub-acute toxicity of Jonlon-5 were also evaluated.  
 
Material and methods  
 
Preparation of Jonlon-5 
Jonlon-5 herbal medicine was prepared in the 
Institute of Traditional Medicine and Technology  
of Mongolia (Table 1). The crude components of 
Jonlon-5 were authenticated by experts from 
Department of Botany, Institute of Biology, 
Mongolia. One gram of crushed dried plant  
material was dissolved into 100 mL of distilled or 
deionized water and boiled at 100°C for 15 min. The 
prepared solution was used for the tests. 
 
Experiment animals 
The current study was performed on Wistar  
albino rats of both sexes weighting 200 to 250 g at  
the pharmacology laboratory of the Institute of 
Traditional Medicine and Technology of Mongolia. 
The animals were kept and followed at standard 
laboratory housing conditions (12 h/12 h light/dark 
cycle). They were fed with pellets and sterilized  
tap water.  
For the acute study, healthy white mice of both 
sexes weighting 22–28 g were taken from the animal 
house attached to the Institute of Traditional Medicine 
and Technology of Mongolia and used after one week 
of quarantine. All experiments were carried out in 
accordance with the institutional guideline for the care 
and use of laboratory animals. The ethical approval 
was sought from the Ethics Committee of the 
Mongolian National University of Medical Sciences.  
 
Acute toxicity test 
In animals, a single oral administration of Jonlon-5 
showed no toxicity at a dose of up to 2000 mg/kg. 
Accordingly, a dose of 2000 mg per kg was used as 
the maximum dose as recommended by the current 
guidelines of OECD. Thirty mice of each sex were 
randomly placed to two groups with fifteen mice per 
group. The animals in treatment group received a 
single dose of 2000 mg/kg via gavage. Control mice 
were given an equal amount of distilled water. After 
oral administration, all clinical signs were recorded 
before and after dosing at 1,2,4 and 24 h.  
 
Sub-acute toxicity test 
For the sub-acute toxicity test, 40 albino rats were 
randomized into 04 groups with ten rats per group. 
The animals in the control group were administered 
with 0.5 mL of saline once daily for 28 days. The 
animals in the other 03 groups were orally treated via 
oral administration of 100, 200 and 500 mg/kg of 
body weight of Jonlon-5, respectively, for 28 days. 
The rats were under constant daily observation for 
any signs of toxicity and their body weights were also 
recorded weekly throughout the experimental period. 
On day 29 of the experiment, all the animals in the  
04 groups were anesthetized under ketamine 
hydrochloride (80 mg/kg). Blood samples or clots 
were collected by cardiac puncture for biochemical 
investigation and centrifuged according to groups. 
The serum was separated into sterile bottles for 
biochemical analysis.  
 
Carrageenan-induced inflammation 
The animals were randomized into 04 groups  
(ten in each group): normal control (NC), 
inflammation, indomethacin (IMC), and Jonlon-5 
(Jonlon-5 at 100 mg/kg of body weight) groups.  
The rats in the control and inflammation groups  
were administered distilled water orally (5 mL/kg of 
body weight). The rats in the IMC group were given 
Table 1 — Crude components of Jonlon-5 (1 g) 
Mongolian name Scientific name Used part Amount (g) 
Unegensuulkheilider Sophora alopecuroides L. Root 0.270 
Jurur Terminalia chebula Fruit 0.270 
Arur Gardenia jasminoides Herb 0.176 
Barur Terminalia bellirica Fruit 0.168 
Sormuustdegd Gentiana barbata Fruit 0.140 
Total amount   1.00 
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oral indomethacin (10 mg/kg of body weight) 2 h 
prior to the induction of arthritis. Indomethacin has 
been widely used for arthritis treatment of because  
of its anti-inflammation and analgesic activities.  
The Jonlon-5 group received Jonlon-5 (100 mg/kg  
of body weight) 2 h prior to the induction of 
inflammation. Inflammation was induced by 0.1 mL 
1% carrageenan. Paw volume was measured at base 
line, 30,60,120, and 240 min after induction with a 
plethysmometer. After 4 h, the rats were sacrificed, 
and blood was collected for various analyses.  
 
Biochemical analysis 
Determination of the level of MDA was 
determined using the fluorimetric method according 
to athiobarbituric acid test. In brief, 0.5 mL of plasma 
was heated in a boiling water bath for 15 min with a 
solution of 0.68% 2.5 mL thiobarbituric acid and 
followed by incubating for 15 min on ice. The 
mixture then was centrifuged at 12000 rpm for 5 min 
at 4°C. The MDA was spectro fluorometrically 
determined using a synchronous technique with 
excitation at 532 nm.  
 
Plasma levels of cytokines 
After being allowed to stand for 30 min, the blood 
was centrifuged at 3000 rpm/min for 10 min at  
4°C; then, plasmas were collected for analysis.  
The serum concentrations of the tumor necrosis 
factor-alpha (TNF-α) and interleukin-1β (IL-1β) were 
determined using a commercial enzyme-linked 
immunosorbent assay (ELISA) method (ELISA kit, 
Republic of China). 
 
Statistical Analyses 
The data are expressed as the mean ± standard 
deviation. A one-way ANOVA was performed to 
identify the difference between groups, and followed 
with Tukey' s test. Statistical significance was set at 
the level of p<0.05. The statistical analyses were 
carried out using the Statistical Package for the Social 
Sciences (SPSS) version 20.0 for Windows. 
 
Results 
 
Acute toxicity of Jonlon-5 
We evaluated the acute toxicity of Jonlon-5.  
There were no significant differences in body  
weight change findings between the Jonlon-5 and 
NC groups, and no clinical signs were observed in the 
Jonlon-5 group.  
Sub-acute toxicity 
At the end of the experiment, there was a slight 
weight reduction in the Jonlon-5 treated rat groups 
compared to the control, but it was not statistically 
significant. This indicates the healthy status of the  
rats following Jonlon-5 decoction. Serum amino 
transferases (ALT and AST) and alkaline phosphatase 
(ALP) activity significantly increased in a dose-
related manner when the rats received various doses 
of Jonlon-5. ALT and AST activities were 
significantly higher in the 500 mg/kg body weight 
treated group when compared with the others 
(p<0.05). ALP activity showed no significant 
difference compared with the others (Fig. 1).  
 
Effects of Jonlon-5 on carrageenan-induced arthritis 
The administration of carrageenan in the 03 groups 
led to a time dependent rise in size of paw,  
which reached a maximum at 4 h. Compared  
to the control group, pre-treatment of Jonlon-5  
at a concentration of 100 mg/kg of body weight 
significantly (p<0.05) reduced the development of 
paw edema, as shown in Fig. 2.  
 
Effects of Jonlon-5 on MDA concentration 
The level of MDA which is a product of lipid 
peroxidation, was significantly elevated in the 
inflammation group as compared those in the NC 
group. However, the IMC group exhibited a 
significant fall in MDA levels compared with the 
inflammation group. In addition, the Jonlon-5  
group have shown a significant decrease in the  
level of MDA (p<0.05) compared to other groups 
(Fig. 3).  
  
Fig. 1 — Effect of Jonlon-5 on the activity of serum liver 
enzymes. Normal control group: n=10; Jonlon-5 100 mg/kg body 
weight group: n=10; Jonlon-5 200 mg/kg body weight group:
n=10; Jonlon-5 500 mg/kg body weight group n=10. Data are
reported as mean ± SD. Data with * are significantly different 
(p<0.05) 
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Fig. 2 — Effect of Jonlon-5 on Carrageenan-induced rat paw 
edemaNormal control group: n=10; Inflammation group n=10; 
Indomethacin 10 mg/kg body weight group: n=10; Jonlon-5  
100 mg/kg body weight group: n=10; Data with * are significantly 
different (p<0.05)  
 
  
Fig. 3 — Effect of Jonlon-5 on the level of malondialdehyde 
(MDA). Control (inflammation) group: n=10; Indomethacin  
10 mg/kg body weight group: n=10; Jonlon-5 100 mg/kg body 
weight group: n=10. Data are reported as mean ± SD. Data with * 
are significantly different (p<0.05). 
 
Effects of Jonlon-5 on the release of pro-inflammatory 
cytokines of plasma  
The in vivo anti-inflammatory activity of Jonlon-5 
was also examined by assessing the levels of TNF-α 
and IL-1β by ELISA. As Fig. 4 presents, the TNF-α 
and IL-1β levels elevated significantly in plasma after 
carrageenan-induced inflammation compared with the 
NC group. However, pre-treatment with Jonlon-5 
(100 mg/kg of bodyweight) decreased TNF-α and IL-
1β productions in plasma and was significantly 
different compared to other groups (p<0.05). 
Interestingly, Jonlon-5 at 100 mg/kg of bodyweight 
significantly suppressed the release of cytokines 
including TNF-α and IL-1β, which was clearly 
comparable to the effect of the non-steroid anti-
inflammatory medication In domethac in (10 mg/kg 
of body weight).  
  
Fig. 4 — Effect of Jonlon-5 on the expression of tumor necrosis 
factor (TNF-α) and interleukin (IL-1β) protein in plasma. Normal 
control group: n=10; Indomethacin 10 mg/kg body weight group: 
n=10; Jonlon-5 100 mg/kg body weight group: n=10. Data are 
reported as mean ± SD. Data with * are significantly different 
(p<0.05) 
 
Discussion and conclusion 
In traditional medicine, combinations of multiple 
herbs are used to increase their pharmacological 
activity and reduce adverse reactions17. Thus, in this 
study, we focused on whether the combination of 
herbs in Jonlon-5 has anti-inflammatory and anti-
oxidative activities that are associated with a 
reduction in oxidative stress and inflammation and 
whether it can be used safely.  
The acute toxicity study allowed us to determine 
the safety of the materials. The study indicated  
that Jonlon-5 is a safe agent when given orally  
to rats in a single dose at a level of 2000 mg/kg. 
Moreover, no clinical signs of adverse events  
were observed. According to the Guidance on  
Acute Oral Toxicity Testing based on an oral LD50 
value that was recommended by the OECD, Jonlon-5 
may be assigned as class 5 (LD50>2000 mg/kg  
body weight), which was appeared to be the low 
toxicity class18. 
Administration of Jonlon-5 at two different doses 
(100 mg/kg and 200 kg/mg body weight) for 28 days 
had no statistically significant effect on serum levels 
of ALT and AST. The current study showed that 
Jonlon-5 up to 200 mg/kg body weight did not 
indicate any toxicity in the liver for the parameters 
used, ALT and AST. However, serum ALT and AST 
levels were found to increase significantly in rats 
receiving 500 mg/kg body weight of Jonlon-5 when 
compared to the control group. The significant 
increase in ALT and AST suggests that administration 
of high doses of Jonlon-5 may induce destruction of 
liver cells.  
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Carrageenan is often used to produce non-immune-
mediated inflammation when evaluating components 
with potential anti-inflammatory activity. In the current 
study, anti-inflammatory activity of Jonlon-5 is observed 
30 min after carrageenan induction compared to the 
inflammation group. Our results demonstrate that 
Jonlon-5 has an anti-inflammatory effect via reduction 
of paw edema that is associated with carrageenan 
induction. In line with these observed results,  
past studies have shown that the administration of 
Sendeng-4 (Fructus Terminaliae chebulae, Fructus 
Terminaliae belliricae, Fructus Gardenia jasminoides, 
and Fructus Toosendan), and Lider-7 (Radix Sophoroe 
alopecuroides, Radix Inulae helenium, Fructus 
Gardeniae, Fructus Terminalia belliricae, Fructus  
T. chebulae, Herba Gentiana barbatae, and Herba 
Lagotis integrifoliae), which have similar components 
asJonlon-5, exhibited an anti-inflammatory effect on 
both acute and chronic experimental inflammation19-21.  
According to the literature, carrageenan induced 
inflammation is associated with free radicals that lead 
to elevated lipid peroxidation6. MDA, a product of lipid 
per oxidation, can be used as a biomarker of oxidative 
stress in tissues and plasmas. In the current study, we 
found that Jonlon-5 attenuated the rise in MDA level in 
plasma, indicating that Jonlon-5 can weaken the 
process of lipid per oxidation implicated in the 
pathogenesis of carrageenan induced inflammation.  
TNF-α and IL-1β are inflammatory cytokines that 
are released during inflammation process and play a 
significant role in defenses of organisms. Several 
studies have demonstrated an inhibition effect of 
various traditional medical treatments on the levels of 
TNF-α and IL-1β. Wen et al. reported that traditional 
Chinese herbs inhibited the release of inflammatory 
cytokines as well as levels of nitric oxide synthase 
and cyclooxygenase-2 in a carrageenan-induced paw 
edema22. Similarly, our study showed that pre-
treatment with Jonlon-5 reduced levels of TNF- and 
IL-1β cytokines in plasma.  
Our study has some limitations to note. There was 
no histological examination to confirm the therapeutic 
effect of Jonlon-5 in an experimental model of 
arthritis. Another limitation of the study is the 
inability to include various doses and hence to 
determine the dose-dependent anti-inflammatory 
effect. This would have made the study more 
comprehensive, although the safe dose the authors 
chose provided a positive result.  
In conclusion, our findings suggest that Jonlon-5 is 
a safe drug with some anti-inflammatory effect in an 
acute model. It was revealed that Jonlon-5 can 
suppress the release of MDA, IL-6 and TNF-α in 
plasma. Jonlon-5 is a promising anti-inflammatory 
agent against inflammation but can cause mild liver 
damage at high doses.  
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